Sign in
4

Changes in Ownership

aTYR PHARMA INC Filed Acc 0001209191-23-026067

Director acquired 6,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SCHIMMEL PAUL Director 2023-04-26 Option exercise +6,000 8,890 D
Derivatives
SCHIMMEL PAUL Director 2023-04-26 Option exercise · Restricted Stock Unit −6,000 0 D
Loading xslF345X04/doc4.xml…